Integrated machine learning and molecular dynamics-driven multi-target virtual screening of FDA-approved drugs for drug repurposing in breast cancer.


Kırboğa K. K., Acar Ş., Şen M., Rudrapal M.

In silico pharmacology, vol.14, no.2, pp.171, 2026 (Peer-Reviewed Journal)